| scholarly article | Q13442814 |
| P50 | author | Wendy Barclay | Q20005716 |
| Olivier Moncorgé | Q55743797 | ||
| P2093 | author name string | J Ellis | |
| J Goudsmit | |||
| C McLeod | |||
| C Bull | |||
| C I Thompson | |||
| W Koudstaal | |||
| L C S Hartgroves | |||
| M J E Havenga | |||
| P2860 | cites work | Generation of influenza A viruses entirely from cloned cDNAs | Q29616768 |
| Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. | Q30327772 | ||
| The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. | Q30328006 | ||
| Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine. | Q30351951 | ||
| The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. | Q30352362 | ||
| Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. | Q30359842 | ||
| Enhanced growth of seed viruses for H5N1 influenza vaccines | Q30363037 | ||
| Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics. | Q30376923 | ||
| Generation of candidate human influenza vaccine strains in cell culture - rehearsing the European response to an H7N1 pandemic threat | Q30376964 | ||
| Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors | Q30452892 | ||
| Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin | Q30913948 | ||
| Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus | Q33806746 | ||
| Functional balance between haemagglutinin and neuraminidase in influenza virus infections | Q34126466 | ||
| NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response. | Q35784659 | ||
| Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective | Q35844791 | ||
| MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells | Q36747588 | ||
| Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK. | Q37444287 | ||
| Receptor binding specificity of recent human H3N2 influenza viruses | Q38301903 | ||
| Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs | Q38350824 | ||
| Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs | Q40035682 | ||
| A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin | Q40415552 | ||
| The growth of attenuated influenza vaccine donor strains in continuous cell lines. | Q40476941 | ||
| Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host | Q40577158 | ||
| Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes | Q40774660 | ||
| Development of a mammalian cell (Vero) derived candidate influenza virus vaccine | Q41021315 | ||
| Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses | Q41643902 | ||
| Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics | Q42755170 | ||
| Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04 (H3N2) increase virus growth in embryonated chicken eggs | Q45414991 | ||
| Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. | Q45729695 | ||
| Evidence for host-cell selection of influenza virus antigenic variants | Q45804806 | ||
| Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture | Q47773239 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2973-2979 | |
| P577 | publication date | 2010-02-25 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs | |
| P478 | volume | 28 |
| Q45325112 | A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 influenza A Virus in Cells |
| Q45778868 | A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. |
| Q28084739 | Cell culture-based influenza vaccines: A necessary and indispensable investment for the future |
| Q35706440 | Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates. |
| Q39585445 | Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds |
| Q92450354 | Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility |
| Q90000054 | Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus |
Search more.